» Articles » PMID: 23875013

Incorporation of Bone Marrow Cells in Pancreatic Pseudoislets Improves Posttransplant Vascularization and Endocrine Function

Overview
Journal PLoS One
Date 2013 Jul 23
PMID 23875013
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Failure of revascularization is known to be the major reason for the poor outcome of pancreatic islet transplantation. In this study, we analyzed whether pseudoislets composed of islet cells and bone marrow cells can improve vascularization and function of islet transplants. Pancreatic islets isolated from Syrian golden hamsters were dispersed into single cells for the generation of pseudoislets containing 4×10(3) cells. To create bone marrow cell-enriched pseudoislets 2×10(3) islet cells were co-cultured with 2×10(3) bone marrow cells. Pseudoislets and bone marrow cell-enriched pseudoislets were transplanted syngeneically into skinfold chambers to study graft vascularization by intravital fluorescence microscopy. Native islet transplants served as controls. Bone marrow cell-enriched pseudoislets showed a significantly improved vascularization compared to native islets and pseudoislets. Moreover, bone marrow cell-enriched pseudoislets but not pseudoislets normalized blood glucose levels after transplantation of 1000 islet equivalents under the kidney capsule of streptozotocin-induced diabetic animals, although the bone marrow cell-enriched pseudoislets contained only 50% of islet cells compared to pseudoislets and native islets. Fluorescence microscopy of bone marrow cell-enriched pseudoislets composed of bone marrow cells from GFP-expressing mice showed a distinct fraction of cells expressing both GFP and insulin, indicating a differentiation of bone marrow-derived cells to an insulin-producing cell-type. Thus, enrichment of pseudoislets by bone marrow cells enhances vascularization after transplantation and increases the amount of insulin-producing tissue. Accordingly, bone marrow cell-enriched pseudoislets may represent a novel approach to increase the success rate of islet transplantation.

Citing Articles

Standard Protocols for Characterising Primary and In Vitro-Generated Human Hepatocytes.

Heydari Z, Gramignoli R, Piryaei A, Zahmatkesh E, Pooyan P, Seydi H J Cell Mol Med. 2025; 29(3):e70390.

PMID: 39910642 PMC: 11798750. DOI: 10.1111/jcmm.70390.


Islet Transplantation: Current Limitations and Challenges for Successful Outcomes.

Langlois A, Pinget M, Kessler L, Bouzakri K Cells. 2024; 13(21.

PMID: 39513890 PMC: 11544954. DOI: 10.3390/cells13211783.


In Vitro Strategies to Vascularize 3D Physiologically Relevant Models.

Dellaquila A, Le Bao C, Letourneur D, Simon-Yarza T Adv Sci (Weinh). 2021; 8(19):e2100798.

PMID: 34351702 PMC: 8498873. DOI: 10.1002/advs.202100798.


Darbepoetin-α increases the blood volume flow in transplanted pancreatic islets in mice.

Menger M, Nalbach L, Wrublewsky S, Glanemann M, Gu Y, Laschke M Acta Diabetol. 2020; 57(8):1009-1018.

PMID: 32221724 PMC: 8318962. DOI: 10.1007/s00592-020-01512-w.


Delayed revascularization of islets after transplantation by IL-6 blockade in pig to non-human primate islet xenotransplantation model.

Min B, Shin J, Kim J, Kang S, Kim H, Yoon I Xenotransplantation. 2017; 25(1).

PMID: 29210476 PMC: 5903442. DOI: 10.1111/xen.12374.


References
1.
Menger M, Yamauchi J, Vollmar B . Revascularization and microcirculation of freely grafted islets of Langerhans. World J Surg. 2001; 25(4):509-15. DOI: 10.1007/s002680020345. View

2.
Hess D, Li L, Martin M, Sakano S, Hill D, Strutt B . Bone marrow-derived stem cells initiate pancreatic regeneration. Nat Biotechnol. 2003; 21(7):763-70. DOI: 10.1038/nbt841. View

3.
Miller R, Cirulli V, Diaferia G, Ninniri S, Hardiman G, Torbett B . Switching-on survival and repair response programs in islet transplants by bone marrow-derived vasculogenic cells. Diabetes. 2008; 57(9):2402-12. PMC: 2518491. DOI: 10.2337/db08-0244. View

4.
Korsgren O, Nilsson B, Berne C, Felldin M, Foss A, Kallen R . Current status of clinical islet transplantation. Transplantation. 2005; 79(10):1289-93. DOI: 10.1097/01.tp.0000157273.60147.7c. View

5.
Faust A, Rothe H, Schade U, Lampeter E, Kolb H . Primary nonfunction of islet grafts in autoimmune diabetic nonobese diabetic mice is prevented by treatment with interleukin-4 and interleukin-10. Transplantation. 1996; 62(5):648-52. DOI: 10.1097/00007890-199609150-00019. View